• to decreased the risk of severe cardiovascular (heart and blood vessel) complications in Grown ups with type two diabetes and heart problemsCalifornia biotech behemoth Amgen ditched programs for an experimental weight loss pill in May perhaps but remains to be hoping to get a slice of the marketplace with MariTide, a month to month injection th